ATE553755T1 - Stärke enthaltende beschichtungszusammensetzung - Google Patents

Stärke enthaltende beschichtungszusammensetzung

Info

Publication number
ATE553755T1
ATE553755T1 AT07789340T AT07789340T ATE553755T1 AT E553755 T1 ATE553755 T1 AT E553755T1 AT 07789340 T AT07789340 T AT 07789340T AT 07789340 T AT07789340 T AT 07789340T AT E553755 T1 ATE553755 T1 AT E553755T1
Authority
AT
Austria
Prior art keywords
coating composition
containing coating
starch containing
starch
formulations
Prior art date
Application number
AT07789340T
Other languages
German (de)
English (en)
Inventor
Gisela Fridrun Podczeck
Ana Cristina Teixeira De Almeida Freire
Original Assignee
Univ Sunderland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0614933A external-priority patent/GB0614933D0/en
Priority claimed from GB0617215A external-priority patent/GB0617215D0/en
Application filed by Univ Sunderland filed Critical Univ Sunderland
Application granted granted Critical
Publication of ATE553755T1 publication Critical patent/ATE553755T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Biological Depolymerization Polymers (AREA)
AT07789340T 2006-07-27 2007-07-20 Stärke enthaltende beschichtungszusammensetzung ATE553755T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0614933A GB0614933D0 (en) 2006-07-27 2006-07-27 Composition
GB0617215A GB0617215D0 (en) 2006-09-01 2006-09-01 Composition
PCT/GB2007/050428 WO2008012573A1 (en) 2006-07-27 2007-07-20 Coating composition comprising starch

Publications (1)

Publication Number Publication Date
ATE553755T1 true ATE553755T1 (de) 2012-05-15

Family

ID=38698207

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07789340T ATE553755T1 (de) 2006-07-27 2007-07-20 Stärke enthaltende beschichtungszusammensetzung

Country Status (10)

Country Link
US (1) US20090285863A1 (enExample)
EP (1) EP2046306B8 (enExample)
JP (1) JP2009544684A (enExample)
AT (1) ATE553755T1 (enExample)
AU (1) AU2007279036A1 (enExample)
BR (1) BRPI0715362A2 (enExample)
CA (1) CA2658915A1 (enExample)
MX (1) MX2009001085A (enExample)
RU (1) RU2440104C2 (enExample)
WO (1) WO2008012573A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011512411A (ja) 2008-02-19 2011-04-21 マクニール−ピーピーシー・インコーポレーテツド 高アミロース含量を有するデンプンを含有する浸漬コーティングされた組成物
ES2425762T3 (es) 2008-10-27 2013-10-17 Roquette Freres Polímero insoluble en agua: revestimientos de película a base de derivados de almidón modificado para la liberación dirigida al colon
GB2567493B (en) * 2017-10-13 2019-12-18 Altus Formulation Inc Starch-based release modifying excipients and pharmaceutical compositions derived therefrom
GB201905940D0 (en) * 2019-04-29 2019-06-12 Intract Pharma Ltd 5-aminolevulinic acid for the local treatment of inflammatory bowel disease

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3034592B2 (ja) * 1990-11-20 2000-04-17 わかもと製薬株式会社 経口用固形製剤及びその製造法
GB9722426D0 (en) * 1997-10-23 1997-12-24 Univ London Pharmacy Controlled release formulations
US6514526B1 (en) * 1998-03-27 2003-02-04 Valtion Teknillinen Tutkimuskeskus Coated starch capsules and a process for producing them
FR2785539B1 (fr) * 1998-11-06 2004-04-09 Prographarm Laboratoires Particules enrobees d'ibuprofene cristallin granule
EP1137011B1 (en) * 2000-03-21 2008-12-10 STMicroelectronics S.r.l. String programmable nonvolatile memory with NOR architecture
GB0203421D0 (en) * 2002-02-13 2002-04-03 Alizyme Therapeutics Ltd Composition
US6703044B1 (en) * 2002-10-25 2004-03-09 Dexcel Pharma Tech, Ltd Venlafaxine formulations
US8088414B2 (en) * 2006-02-07 2012-01-03 Fmc Corporation Latex or pseudolatex compositions, coatings and coating processes

Also Published As

Publication number Publication date
AU2007279036A1 (en) 2008-01-31
MX2009001085A (es) 2009-03-23
EP2046306A1 (en) 2009-04-15
CA2658915A1 (en) 2008-01-31
US20090285863A1 (en) 2009-11-19
WO2008012573A1 (en) 2008-01-31
BRPI0715362A2 (pt) 2013-06-18
RU2009106260A (ru) 2010-09-10
JP2009544684A (ja) 2009-12-17
EP2046306B8 (en) 2012-06-27
RU2440104C2 (ru) 2012-01-20
EP2046306B1 (en) 2012-04-18

Similar Documents

Publication Publication Date Title
IL273422A (en) Methods and systems for extracorporeal organ treatment
CL2007002640A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
CL2007002642A1 (es) Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer.
MX2009003821A (es) Compuestos de n-aril pirazol para usarse contra la diabetes.
IL227934A (en) An immunogenic preparation containing polysaccharide or oligosaccharide from s. type 5 or 8 aureus and various aspects related to it
WO2007127333A3 (en) Compositions for the treatment and prevention of eyelid swelling
WO2008048288A3 (en) Novel nanoparticles and use thereof
NO20082538L (no) Stabiliserte lantankarbonatsammensetninger
BRPI0718927A2 (pt) Método de imunização contra os quatro sorotipos da dengue.
ECSP077299A (es) Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos
BRPI0807012A2 (pt) Uso de inseticidas, método de reduzir ou evitar o efeito fitotóxico de fungicidas, e, agente.
TR200801337T1 (tr) Suda zayıf çözülebilen farmasötik ajanlar ve antimikrobiyal ajanlar içeren kompozisyonlar.
NO20091183L (no) Derivater av 4-(N-azacykloalkyl)-anilider, fremgangsmåte for fremstilling av slike forbindelser, preparater omfattende slike forbindelser samt anvendelse av slike forbindelser for forhindring eller behandling av sykdom
EP2476461A3 (en) Formulations For Cancer Treatment
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
WO2008083157A3 (en) Altering pgc-1alapha, ampk, fiaf, or the gastrointestinal microbiota as a means to modulate body fat and/or weight loss in a subject
WO2006135854A3 (en) Antiseptic compositions
NO20075111L (no) Farmasoytisk sammensetning
WO2007095258A3 (en) Rhamnolipid compositions and related methods of use
JP2009516717A5 (enExample)
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
WO2007056073A3 (en) Medical device with a coating comprising an active form and an inactive form of therapeutic agent(s)
EP2300599A4 (en) INCREASING THE EFFECTIVENESS OF CELL THERAPY, INCLUDING TREATMENT WITH ALPHA-1-3-FUCOSYLTRANSFERASE
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
WO2009071689A3 (de) 5-halogen-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen